Physician Assistant · Willow Grove, PA
NPI
1134671605
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2325 Maryland Rd Ste 100
Willow Grove, PA, 19090
Phone (215) 657-1315
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,488
52 services
Medicare patients, 2024
40
Average age 64
Drug cost, 2024
$766K
6,479 prescriptions
Company payments, 2025
$1,582
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Feba Geevarghese was code 99214 (office e&m - established), 35 times for 27 patients. In total Feba Geevarghese billed 52 services in 4 codes, and Medicare paid $3,488.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 35 | 27 | $70.04 | $2,451 |
| 99213 Office E&M - Established | Office | 14 | 14 | $63.14 | $884 |
By year: 2022 $5,870 for 83 services; 2023 $11K for 146 services; 2024 $3,488 for 52 services.
Medicare prescription drug claims, 2024
In 2024, the drug Feba Geevarghese prescribed most often to Medicare patients was Oxycodone Hcl, with 1,122 prescriptions and refills. In total Feba Geevarghese wrote 6,479 Medicare prescriptions that cost $766K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,122 | 1,122 | 193 | $19K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 904 | 904 | 146 | $21K |
| Cyclobenzaprine Hcl Generic | 486 | 496 | 89 | $2,874 |
| Gabapentin Generic | 486 | 506 | 100 | $4,562 |
| Lidocaine Generic | 350 | 357 | 85 | $21K |
| Diclofenac Sodium Generic | 330 | 338 | 77 | $39K |
| Pregabalin Generic | 253 | 267 | 50 | $2,883 |
| Tizanidine Hcl Generic | 235 | 249 | 57 | $2,964 |
| Ztlido Lidocaine | 221 | 234 | 58 | $207K |
| Meloxicam Generic | 194 | 204 | 48 | $591 |
| Morphine Sulfate Er Morphine Sulfate | 165 | 165 | 32 | $3,236 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 151 | 151 | 32 | $4,345 |
| Baclofen Generic | 148 | 160 | 33 | $1,901 |
| Naloxone Hcl Generic | 144 | 144 | 132 | $11K |
| Xtampza Er Oxycodone Myristate | 114 | 114 | 26 | $40K |
Brand drugs: 763 claims; generic drugs: 5,716 claims; opioid claims: 2,896.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Feba Geevarghese $1,582 ($1,582 in general payments such as food, travel and fees) from 14 companies. The largest payer was Averitas Pharma Inc. with $304.
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 7 | $304 |
| Abbott Laboratories ABT | 6 | $208 |
| Collegium Pharmaceutical, Inc. COLL | 14 | $192 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $163 |
| Scilex Pharmaceuticals Inc. | 9 | $158 |
| Alkermes, Inc. ALKS | 4 | $140 |
| Boston Scientific Corporation BSX | 3 | $129 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $75.49 |
| Zimmer Biomet Holdings, Inc. ZBH | 1 | $49.43 |
| Valinor Pharma, LLC | 2 | $46.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.